Kala Pharmaceuticals Reports Second Quarter 2018 Financial Results

Magenta Therapeutics Reports Recent Operational Progress and Second Quarter 2018 Financial Results

Sesen Bio Announces Vicinium Granted Fast Track Designation by FDA for Treatment of Non-Muscle Invasive Bladder Cancer

Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases

Ambys Medicines Launches with $140 Million to Pioneer Regenerative Medicine Therapies for Serious Liver Diseases